We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

World First: Phase 1 Trial of Chlamydia Vaccine Finds That It Is Safe and Provokes Immune Response

News   Aug 13, 2019 | Original story from The Lancet

 
World First: Phase 1 Trial of Chlamydia Vaccine Finds That It Is Safe and Provokes Immune Response

Credit: Pixabay

 
 
 

RELATED ARTICLES

Brewer's Best Friend Stems From Accidental Encounter

News

Pilsner yeast, used to make hundreds of billions of liters of pilsner and other lagers every year, was created from an accidental encounter between two species of yeast.

READ MORE

"Undetectable Equals Untransmittable" Now the Accepted HIV Message

News

People living with HIV who achieve and maintain an undetectable viral load by taking antiretroviral therapy as prescribed do not sexually transmit HIV to others. The U.S. Centers for Disease Control and Prevention estimates this strategy is 100% effective against the sexual transmission of HIV.

READ MORE

E-cigarette User Found to Have Rare Form of Lung Scarring Typically Seen in Metal Workers

News

Researchers studying a patient with a rare lung disease called hard-metal pneumoconiosis believe that the disease may have been caused by vaping.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE